A detailed history of Evexia Wealth LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Evexia Wealth LLC holds 12,135 shares of LLY stock, worth $10.1 Million. This represents 3.87% of its overall portfolio holdings.

Number of Shares
12,135
Previous 11,671 3.98%
Holding current value
$10.1 Million
Previous $10.1 Billion 7.87%
% of portfolio
3.87%
Previous 3.79%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$772.14 - $960.02 $358,272 - $445,449
464 Added 3.98%
12,135 $10.9 Billion
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $199,339 - $249,986
-275 Reduced 2.3%
11,671 $10.1 Billion
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $1.91 Million - $2.56 Million
3,231 Added 37.07%
11,946 $8.98 Billion
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $123,419 - $145,495
235 Added 2.77%
8,715 $5.82 Billion
Q3 2023

Oct 30, 2023

BUY
$434.7 - $599.3 $3.69 Million - $5.08 Million
8,480 New
8,480 $4.97 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Evexia Wealth LLC Portfolio

Follow Evexia Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evexia Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evexia Wealth LLC with notifications on news.